September 25th 2023
Members of the ACIP voted on Friday to recommend Pfizer’s maternal bivalent RSVpreF vaccine to protect newborns from severe RSV illness.
September 5th 2023
Results from a new study suggest that postnatal SSRI treatment may be beneficial in the long term for both women with postpartum depression and their children.
August 22nd 2023
The FDA approved Abrysvo for use in pregnant individuals to prevent LRTD and severe LRTD caused by RSV in infants from birth through 6 months of age.
August 7th 2023
The US FDA approved zuranolone 50 mg as the first oral, once-daily treatment for postpartum depression in adults.
July 13th 2023
The US FDA approved norgestrel as the first daily oral contraceptive to be available over the counter, without a prescription.
Oral Contraceptive Gets Unanimous Recommendation for OTC Use from FDA Advisory Panel
Opill, a progestin-only oral contraceptive, if approved by the FDA, would be the first an only form of birth control in the US available without a physician's prescription.
Depression Linked to Hormonal Contraception Associated with Higher Risk of Postpartum Depression in Large Study of First-time Mothers
Women with prior HC-associated depression had a higher risk of developing a depressive episode during pregnancy and postpartum than women with non-HC-associated depression.
Daily Dose: Prenatal Depression & Risk of New CVD Postpartum
Your daily dose of clinical news you may have missed.
Prenatal Depression Associated with New CVD Diagnosis Postpartum, According to New Data
Pregnant women with prenatal depression were found to be more likely to be diagnosed with new CVD within 2 years of delivery than those without depression.
Health Status, Not Age, Associated with Rise in Adverse Pregnancy Outcomes in the US
ACC 2023. Increasing rates of adverse pregnancy outcome over the last decade are largely attributable to a woman’s health status before she gets pregnant, rather than age, according to new research.
Daily Dose: Migraine and Pregnancy Complications
Daily Dose: Preeclampsia and Risk of Premature Ischaemic Cardiovascular Disease
Mediterranean Diet Associated with Lower Risk of Adverse Pregnancy Outcomes, Suggests New Study
Findings showed that greater concordance to the Mediterranean diet was linked to a 21% lower risk of developing any adverse pregnancy outcomes.
Drug Overdose Deaths Reach Record High among Pregnant, Postpartum Women in US
Drug overdose deaths increased approximately 81% among pregnant and postpartum women in the US from 2017 to 2020, according to new research.
Study: Surprising Number of Postpartum Hypertension Cases Occurred More than 6 Weeks After Birth
Analysis of women who did not have high blood pressure while pregnant found that 1 in 10 were diagnosed with hypertension in the year after delivery.
Daily Dose: Social Vulnerabilities Linked to Cardiometabolic Risk in Pregnant Women
Daily Dose: Racial Disparities among Women Seeking Fertility Care
Social Vulnerabilities Linked to Cardiometabolic Risk in Pregnant Women in US, New Study Finds
AHA 2022: Study authors say more research is needed to investigate the impact of targeting social determinants of health to improve cardiometabolic risk and mortality in pregnant women.
Survey Finds Racial Disparities among Women Seeking Fertility Care during Pandemic
Black women seeking fertility care were less likely to report getting COVID-19 vaccine and were unsatisfied with how major health care systems handled the pandemic.
Study Analyzing Efficacy of Nonhormonal Contraceptive Gel, Phexxi, for Prevention of Chlamydia, Gonorrhea Completes Last Subject Last Visit
Top-line data from the EVOGUARD clinical trial examining the efficacy of Phexxi for the prevention of chlamydia and gonorrhea are expected in October 2022.
Study: Investigational RSV Vaccine Elicited Neutralizing Antibody Responses in Pregnant Women
Results from a phase 2b trial showed that a bivalent RSV prefusion F protein-based vaccine was safe and led to higher neutralizing antibody responses in pregnant women.
Antihypertensive Treatment during Pregnancy Linked to Better Outcomes, According to New NIH Study
ACC 2022: Use of antihypertensive therapy in pregnant women was associated with better pregnancy outcomes, such as preeclampsia and fetal or neonatal death.
Migraine Linked to Higher Risk of Pregnancy Complications in Preliminary Study
Researchers also found that women with migraine with aura had a higher risk of preeclampsia than those with migraine without aura.
CDC Encourages Pregnant Individuals to Get COVID-19 Vaccination
The CDC now recommends that pregnant and breastfeeding individuals get vaccinated against COVID-19.
6 New Drugs Approved for Primary Care: Q2 2021
From obesity to pneumococcal disease, we have picked the top 6 FDA-approved drugs every primary care physician should know about from the second quarter.
7 New Drugs for Primary Care: Q2 2019
The end of another quarter means a new list of FDA-approved drugs for primary care. Which ones should you know about? Click through to find out.
Update on Hypertension in Pregnancy
Here: at least 5 tips on hypertensive disorders during pregnancy.
Women at Risk for HIV Open to PrEP
They often willingly accept pre-exposure prophylaxis when offered.
NSAIDs Affect Fertility of Women With Musculoskeletal Pain
NSAIDs may impair fertility in women with mild musculoskeletal pain. Damage is reversible once NSAIDs are discontinued, according to a new study.
Pregnancy Issues and Other Women’s Concerns: A Photo Essay
Pseudosac with ectopic pregnancy, palmar erythema, pemphigoid gestationis, abdominal wall hematoma, dermatomyositis, livedo reticularis-visual presentations of health problems that occur frequently, or exclusively, in women.
Medication Errors in Adults-Case #7: Pregnancy
A 34-year-old woman presents for follow-up of her type 2 diabetes mellitus and starts therapy with lisinopril. She thinks she also may be pregnant. What is the problem?
2 Clarke Drive Cranbury, NJ 08512